Efficacy Study of TLN-232 in Patients With Recurring Metastatic Melanoma

Summary

The objective of this study is to assess the efficacy and safety of TLN-232 used to treat patients with metastatic melanoma that recur/progress after receiving first line systemic therapy.

Timeline

Start

2008-08

Primary completion

2009-12

Completion

2010-10

Outcome

Outcome not reported

Stopped: “License termination.”

Drugs

Indications